Edgewise Therapeutics, Inc.
EWTX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$41 | -$36 | -$41 | -$40 |
| Dep. & Amort. | $1 | $1 | $1 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $8 | $8 | $9 | $0 |
| Change in WC | $1 | -$3 | -$5 | $7 |
| Other Non-Cash | -$4 | -$2 | -$2 | $5 |
| Operating Cash Flow | -$35 | -$33 | -$38 | -$27 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | -$264 | -$122 | -$63 |
| Inv. Sales/Matur. | $0 | $102 | $166 | $84 |
| Other Inv. Act. | $36 | $0 | $0 | $0 |
| Investing Cash Flow | $36 | -$162 | $44 | $21 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $187 | $2 | $3 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $2 | $1 | $0 | -$0 |
| Financing Cash Flow | $2 | $188 | $2 | $3 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $3 | -$7 | $8 | -$3 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $43 | $50 | $42 | $45 |
| End Cash | $46 | $43 | $50 | $42 |
| Free Cash Flow | -$35 | -$33 | -$38 | -$27 |